Canopy Growth may have just made its most ambitious claim yet — can it deliver?
After Canopy Growth shares tanked 8% following disappointing earnings, CEO Bruce Linton said he thinks the company will become a leader the CBD market.
Forget Canada and Buy U.S. Pot Stocks, Says This Investment Firm
Nearly 80% of legal worldwide marijuana sales will come from the United States in 2019.
Curaleaf: Here's how we'll merge 'accessible' cannabis with lifestyle
After the recent acquisition of Select for $950 million, Curaleaf CEO Joseph Lusardi believes his company is poised to take over the cannabis industry.
Curaleaf CEO on acquisition of Select Brand
Curaleaf CEO Joe Lusardi talks acquisition of Select Brand, growing accessibility of his company.
Analysts: Here's the biggest difference between crypto, cannabis markets
At first glance, cannabis and cryptocurrencies seem to have a lot in common. Both comprise highly speculative markets subject to exuberant highs and crushing lows. The legality and regulation of each has...
These are the biggest threats to the cannabis industry, according to top CEOs in the space
The nascent marijuana industry has made significant strides over the past several years. But the once-illicit marijuana market still has hurdles to cross before unlocking its full potential, according...
"Curaleaf is the most accessible cannabis company in the U.S," says the company's CEO
Curaleaf CEO Joseph Lusardi makes the case in 26 seconds.
Sorry, But New York Probably Won't Legalize Marijuana This Year
By Brendan Bures New Yorkers love to joke about its little brother New Jersey, ribbing any and all of that state’s shortcomings, but the pair are two peas on a pod when it comes to marijuana reform. Just...
The Business of Cannabis
Yahoo Finance dives deep into the cannabis industry's rapid expansion and where investors are looking for growth in the space. Join reporters Zack Guzman, Alexis Keenan Weed and Emily McCormick as...
Curaleaf Announces June Conference Attendance
WAKEFIELD, Mass. , June 4, 2019 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA /OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States , today announced its management...
Curaleaf is committed to being the industry’s leading resource in education and advancement through research and advocacy.
Headquartered in Wakefield, Massachusetts, Curaleaf has a presence in 12 states, owns and operates 33 dispensaries, 12 cultivation sites and 10 processing sites with a focus on highly populated, limited license states, including Florida, Massachusetts, New Jersey and New York.
Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It cultivates, processes, markets, and/or dispenses a range of cannabis products in various operating markets, including flower, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, tinctures, lozenges, capsules, and edibles. The company also provides non-cannabis services to licensed cannabis operators in the areas of cultivation, extraction and production, and retail operations. As of January 9, 2019, it operated 39 dispensaries, 12 cultivation sites, and 10 processing sites in 12 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
Delivering Premium Quality ProductsThrough our team of physicians, pharmacists, medical experts and industry visionaries, we have created a premier, branded, cannabis-based therapeutic offering under the Curaleaf brand.
CultivationCuraleaf’s highly qualified, in-house research and development team designs and operates cultivation sites that meet good agricultural practices (GAP) while producing optimal yields of high-quality and consistent medical cannabis.
ProcessingCuraleaf leverages its extensive R+D capabilities to train its staff in superior extraction techniques to formulate premium branded products, including oils for vaporizing, cartridges, concentrates, tinctures, mints, capsules, edibles, and flower pods. Strain-specific terpene profiles have been rolled out in every state.
Dedication to PatientsDedication to Patients – Curaleaf’s dedicated dispensary team have served more than 87,000 registered patients since the inception of operations in each medical state. Its dispensary associates are known for educating and guiding patients through the available product forms, dosing and strains to help each patient make the best choice for their condition.